• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Hodgkins & T-Cell Lymphoma: Diagnosis, Treatment Options & Prognosis

Hodgkins & T-Cell Lymphoma: Diagnosis, Treatment Options & Prognosis

9781622574780
900.84 zł
810.75 zł Save 90.09 zł Tax included
Lowest price within 30 days before promotion: 810.75 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this book, the authors present current research in the study of the diagnosis, treatments options and prognosis of both Hodgkins and T-Cell lymphomas, gathered from across the globe. Topics discussed include the pathology and pathogenesis of Hodgkins lymphoma; total skin electron beam therapy in the treatment of cutaneous T-Cell lymphoma; HIV-associated T-Cell lymphoma; critical mass hypothesis of T-Cell responses and its application in the treatment of T-Cell lymphoma; combined modality therapy, the short term benefits and long term toxicities in Hodgkins lymphoma; and enteropathy-associated T-Cell lymphoma diagnosis and risk-stratification.
Product Details
73987
9781622574780
9781622574780

Data sheet

Publication date
2013
Issue number
1
Cover
hard cover
Pages count
179
Dimensions (mm)
180.00 x 260.00
Weight (g)
488
  • Preface; Pathology & Pathogenesis of Hodgkins Lymphoma:: Analysis of its Status over a Period of Five Decades; Treating Cutaneous T-Cell Lymphoma:: Total Skin Electron Beam Therapy; Hodgkins Lymphoma:: Past & Present Issues; Hodgkins Lymphoma:: Pathogenesis, Diagnosis, Treatment Options & Prognosis; HIV-Associated T-Cell Lymphoma:: Epidemiology, Pathobiology, Clinical Features, Prognosis & Management; Critical Mass Hypothesis of T-Cell Responses & its Application for the Treatment of T-Cell Lymphoma; Combined Modality Therapy in Hodgkin Lymphoma:: Short Term Benefits & Long Term Toxicities- Is there Evidence to De-Escalate Therapy?
Comments (0)